Could silkworm powder boost brain health in Alzheimer's?
NCT ID NCT07638449
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether silkworm pupa powder, taken daily for 12 weeks, can improve memory, daily living skills, and frailty in 100 people with mild-to-moderate Alzheimer's disease. Participants will take the powder twice a day and visit the clinic every 4 weeks for tests including brain scans and blood work. Because there is no placebo group, researchers will compare each person's results to their own starting point.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
silkworm pupa powder
What this could lead to
If it works, this could point toward a simple dietary supplement that helps slow cognitive decline and improve frailty in Alzheimer's patients.
What could go wrong
This is a very early, small study with no placebo group, so results may be due to chance. Silkworm pupa powder is unproven for Alzheimer's, and any benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongde Hospital of Zhejiang Province
Hangzhou, Zhejiang, 310012, China
Contact Phone: •••-•••-•••• Email: •••••@•••••